Are you a pharmaceutical or biotech manufacturer preparing to commercialize a drug and wondering how to support your Phase III clinical trial patients post approval?

In today’s complex access and reimbursement landscape, preparing your patients for the transition from clinical trial to commercial product requires proactive planning and collaboration with multiple stakeholders. While managing patient access and affordability during this transition is achievable, it is essential to understand the necessary support systems and comply with the reporting regulations in various countries.

Join us on November 19th at 4:00PM CEST to hear our experts guide you through the crucial components every manufacturer must have to support trial patients transitioning to the commercial space. They'll also share insights on managing affordability, access, and regulatory compliance, while ensuring comprehensive patient support during this critical phase.

Can't attend the live session? Register, and you'll receive the recording after the event!